PP01.47: PD-(L)1 Inhibitor Monotherapy Versus Chemo-Immunotherapy for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression ≥50%: A Systematic Review and Meta-Analysis with Individual Patient Data
Alessandro Di Federico, Samuele Compagno, Francesco Mantuano, Sara Stumpo et autres
us, it, br (code pays fourni par la source)